China Construction Bank

China Construction Bank (CCB) is one of the world’s largest commercial banks, providing a comprehensive range of financial services including corporate banking, personal banking, and treasury operations. It serves hundreds of millions of customers globally and operates over 13,000 branches in mainland China with an extensive international presence. CCB has no direct drug development or clinical pipeline; however, its investment arm has launched healthcare-focused private equity funds. While CCB itself does not develop therapeutics or medical technologies, its subsidiary CCB International has established the "CCBI Healthcare Fund," which invests in healthcare sectors such as pharmaceutical manufacturing and medical devices. The bank also provides financing for infrastructure projects including those related to healthcare facilities. As a systemically important financial institution headquartered in Beijing and partially state-owned via Central Huijin Investment Company, it ranks among the top global banks by assets and market capitalization.